Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The primary hypotheses under test are that alcohol dependent subjects treated with
mifepristone will report decreased craving for alcohol following alcohol exposure in the
laboratory and report significantly less drinking under naturalistic conditions, than those
treated with placebo.
Phase:
Phase 2
Details
Lead Sponsor:
The Scripps Research Institute
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)